Exelixis | 当期純利益





当期純利益 変化する 日付
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.53B 83M 2025-09
Bayer EUR -963M 764M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 2.2B 891M 2025-09
Cytokinetics USD -306.18M 171.81M 2025-09
Eisai JPY 10.16B 4.32B 2025-09
Eli Lilly USD 5.58B 78M 2025-09
Exelixis USD 193.58M 8.73M 2025-09
Genmab DKK 336M 141M 2025-06
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Incyte USD 424.17M 19.17M 2025-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Xencor USD -6.03M 24.8M 2025-09


Exelixis 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.